Tetralogy of Fallot
Tetralogy of Fallot (TOF) is characterized by four main features: a malaligned, subaortic, membranous VSD, an overriding aorta, right ventricular hypertrophy, and pulmonary stenosis (PS), which may be valvular, subvalvular, and/or supravalvular (
Fig. 4.21). TOF is the most common cause of cyanotic CHD. In fact, although TOF arises in only ˜4 per 10,000 live births, it accounts for 7% to 10% of all CHD. The underlying pathogenesis of TOF is attributed to malposition of the conal septum in relationship to the ventricular endocardial cushion, resulting in lack of normal signaling for membranous septum formation.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
The anatomy in TOF is variable, and several discrete subtypes in addition to the conventional form are recognized. These include TOF with pulmonary atresia (
Fig. 4.22), in which the central PAs are completely discontinuous from the RVOT; TOF with absent pulmonary valve, in which the pulmonic valve is rudimentary or nonexistent, leading to severe pulmonary regurgitation and PA dilation (
Fig. 4.23); and TOF with major aortopulmonary collateral arteries (MAPCAs), in which the MPA is absent or diminutive and MAPCAs supply the lungs.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
TOF is often associated with a right aortic arch (25%); ASDs (15%; referred to as “pentalogy” of Fallot); and coronary artery anomalies, most commonly characterized by the left anterior descending (LAD) arising from the RCA. Presenting clinical features range from asymptomatic murmur or decreased exercise tolerance to hypercyanotic episodes (“tet spells”), typically evident by 2 to 6 months of age. In general, the degree of PS determines the onset and severity
of cyanosis; with only mild RVOT obstruction, neonates may be not cyanotic (“pink tetralogy”). The absent pulmonary valve form of TOF is unique in that the markedly enlarged PAs cause tracheobronchial compression and resultant respiratory distress.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
The classic (although not universal) radiographic findings in TOF include a “boot-shaped heart” with elevation of the cardiac apex due to right ventricular hypertrophy, a concave MPA silhouette, and a large, right-sided aortic arch (
Fig. 4.24A). Pulmonary vascular markings are characteristically diminished but may be normal or engorged in “pink tetralogy” patients without significant PS. Echocardiography is the first-line imaging modality and provides an excellent assessment of the typical intracardiac anatomy in TOF, the magnitude and direction of shunting across the VSD, and the maximum velocity across the RVOT. The maximum velocity can be used to estimate the pressure gradient across the RVOT via the modified Bernoulli equation, Δ
P = 4
V2, where Δ
P is the pressure gradient in millimeters of mercury (mmHg) and
V is the average maximum velocity is meters per second (m/s). Although the main and proximal branch PAs can be visualized, the distal PAs are usually not well evaluated.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
CT offers an excellent anatomical assessment of RVOT morphology, branch PA stenoses, and any MAPCAs (
Fig. 4.24B). MAPCAs usually arise from the thoracic aorta but may originate from the abdominal aorta or the subclavian, internal mammary, intercostal, or even coronary arteries. When MAPCAs are present, for surgical planning purposes, it is important to delineate which segments of the lung are supplied by the native PAs, MAPCAs, or both. For TOF with absent pulmonary valve, CT provides superior assessment of tracheobronchial compression by the aneurysmal PAs. In addition, CT is preferred over MRI for anatomic assessment when metallic stents are present. Lung window CT images may reveal a “mosaic attenuation” pattern related to variations in regional lung perfusion and pulmonary hypertension.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
The major role of MRI in TOF is in postoperative assessment, when surgical material (such as conduits) limits visualization. A typical MRI for postoperative TOF includes evaluation of the following: (1) right ventricular volume and function; (2) RVOT anatomy, caliber, and peak velocity at the level of RVOT obstruction, if present; (3) severity of pulmonary regurgitation and differential branch pulmonary artery regurgitation (quantified using PC techniques); and (4) branch pulmonary artery stenosis (typically imaged with contrast-enhanced MRA). When performed, it is not uncommon for delayed enhancement imaging to demonstrate myocardial scarring in postoperative TOF patients (typically older patients with later repair), although its clinical significance is currently uncertain. MRI has a well-established role in assessing the appropriate timing for pulmonary valve replacement (PVR) in pediatric patients with repaired TOF based on quantitative parameters. In the presence of a pulmonary regurgitation fraction of ≥25%, indications for valve replacement include: (1) an RV end-diastolic volume index (EDVI) >150 mL/m
2 or Z-score >4, (2) an RV/LV EDV ratio >2, (3) a large RVOT aneurysm, (4) a RV ejection fraction (EF) <45% to 47%, or (5) LVEF <55%.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
Cardiac catheterization has limited additional diagnostic utility in TOF prior to initial surgery. Nevertheless, it is useful for quantifying hemodynamics, delineating the central and branch pulmonary arteries and MAPCAs, and demonstrating coronary anomalies. A major and increasing role for catheterization is percutaneous PVR and exchange, techniques that obviate more invasive surgery.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87
Initial treatment for TOF depends on the underlying anatomy. The majority of affected pediatric patients are, at most, minimally cyanotic at initial presentation and undergo elective surgical repair between the ages of 6 months and 1 year of age. Definitive surgical correction consists of VSD closure and relief of RVOT obstruction, which may be performed with infundibulectomy, a transannular patch, or a pulmonary
artery valved conduit (usually a homograft). In pediatric patients with significant symptoms or cyanosis, a modified Blalock-Taussig (BT) shunt, typically consisting of a Gore-Tex graft from the right or left subclavian artery to the ipsilateral pulmonary artery, may be used to augment pulmonary blood flow. Other palliative procedures used as bridges to definitive surgery may include balloon pulmonary valvuloplasty or placement of an RVOT stent. In TOF with pulmonary atresia, initial maintenance of ductal flow is critical and may be accomplished via infusion of prostaglandin E1 (PGE1) and, sometimes, ductal stenting. Treatment in the presence of MAPCAs is complex but, in general, consists of multistage surgeries and catheterization to augment the PAs and allow forward pulmonary blood flow; the use of MAPCAs to supplement the native PAs is known as “unifocalization.” In TOF with absent pulmonary valve, management includes partial resection and repair of the aneurysmal PAs. After definitive repair, pediatric patients with TOF are at risk for complications ranging from RV dysfunction to arrhythmia to sudden death and require long-term monitoring, for instance, to determine the timing of PVR, as previously described.
12,
36,
37,
56,
78,
79,
80,
81,
82,
83,
84,
85,
86,
87